doctor image.png
IMG_2056.jpg
DSC_0191.jpg
8308869963_6a72e9adbd_k.jpg
doctor image.png

The Business of Emerging Medtech


S2N has worked with over 80 emerging medical devices companies who have raised more than $500M since 2011.

SCROLL DOWN

The Business of Emerging Medtech


S2N has worked with over 80 emerging medical devices companies who have raised more than $500M since 2011.

Efficient & Flexible Support:

We emulate the entrepreneurial spirit of our clients by being creative, collaborative, and action oriented. We work with clients at all stages of the product lifecycle, providing full-service strategic marketing support from the highly analytical to the tactical, leveraging a network of like-minded practitioners in regulatory, reimbursement, communications and other disciplines to meet the needs of med tech innovators.

  • Virtual marketing team – scalable and adaptive

  • Project-based support – collaborative and cost-effective

Experience in a Broad Range of Clinical Areas:

  • Vascular devices

  • Drug delivery

  • Surgical devices

  • Orthopedics

  • Neuro-psychiatry devices

  • Point-of-care diagnostics

  • Women’s health

  • Plastic surgery & aesthetics

  • Electrophysiology

Our Services

graphic.PNG
IMG_2056.jpg

Client Case Studies


Client Case Studies


Untitled.png

Situation

  • VC-backed orthopedic device company raising series B
  • Needed to validate market opportunity and economic value proposition

S2N Role

  • Developed market entry strategy and product positioning, incorporated into investor pitch deck
  • Created detailed payer-perspective economic model to support target product price point

Outcome: Received a term sheet from new investor and Raised $27M from new and existing investors

products-image.jpg

Situation

  • Brazilian company with a novel bone graft substitute
  • Deciding whether and how to enter the US market

S2N Role

  • Conducted primary research with target customers, competitors and channel partners to determine requirements for successful US market entry
  • Determined most attractive segments to enter given product features, price points, and channels
  • Developed market forecast model

Outcome: Changed focus of product development strategy

DSC_0191.jpg

Testimonials


“S2N’s deep expertise and accessibility is truly what differentiates them from other consulting firms. They are like an extension of me.”
-VP of Business Development, Diagnostics Company

Testimonials


“S2N’s deep expertise and accessibility is truly what differentiates them from other consulting firms. They are like an extension of me.”
-VP of Business Development, Diagnostics Company

CEO, Endoscopic Therapy Company

"The S2N team worked with us to focus and articulate our company strategy. Their work helped us communicate with investors and raise our $20 million series B round."

CEO, Interventional Device Company 

"S2N has satisfied a wide range of our marketing needs over the last 18 months, from branding & messaging to financial modeling and market intelligence. I appreciate their personal commitment to our small company. I enjoy working with everyone at S2N and consider them part of our team!" 

CEO, Drug Delivery Company

"S2N’s pricing analysis was the best I have seen in over 25 years of being in the business. Their presentation to the Board of Directors was professional both in content and style and well received."

8308869963_6a72e9adbd_k.jpg

About Us


About Us


amy.png

Amy Siegel

Amy is the co-founder of S2N Health, a consulting firm focused on helping companies realize the value of their healthcare technology innovations. Since its founding in 2011, S2N has collaborated with >80 innovative organizations, from start-ups to large multinationals, to bring critical market and commercial insights into product & pipeline decisions, business planning, product launch, fundraising, and business development transactions (buy & sell side). S2N's emerging clients have raised >$500M. Amy's 20+ years of healthcare strategic marketing and business development experience includes VP Marketing roles in two emerging med-tech companies, and 10 years of management strategy consulting with Health Advances and Monitor Company. Prior to entering the healthcare space, Amy was a loan officer and policy analyst with the U.S. Export-Import Bank. Amy earned her B.A. from Tufts University and M.A.L.D. from the Fletcher School of Law and Diplomacy.

Email: asiegel@s2nhealth.com

sam.png

Sam Dodge

Sam joined S2N Health as an Analyst in November 2015. Prior to joining S2N, he worked at Cohealo, a Boston-based healthcare technology startup. At Cohealo, Sam worked on a variety of projects across operations, finance, and marketing. Sam received his B.A. in History and Science from Harvard University. 

Tim Kofol

Tim has applied his analytical and financial skills to the medical device industry for over 10+ years. Before co-founding S2N, Tim worked as a strategic marketing consultant for Seventh Sense Biosystems and as a software engineer for Aspect Medical Systems. At Aspect, Tim helped the company develop new technology for neuro applications of its core EEG platform, creating novel algorithms, leading software development and guiding product planning. Tim received his B.S.E. from Princeton University with a degree in Operations Research and Financial Engineering. He earned his M.B.A. and M.S. in Information Systems at Boston University School of Management, from which he graduated with honors.

Email: tkofol@s2nhealth.com
 

 
rebecca.png

Rebecca Noble

Rebecca joined S2N Health as an Analyst in May 2016. Before joining S2N, Rebecca held a clinical role at a dermatology practice. Rebecca earned her B.S. in Biology at the University of Notre Dame, graduating summa cum laude and is also a member of the Phi Beta Kappa honor society.